Wax-based electronic atomization composition as well as preparation method and application thereof
By using edible wax as an emulsifier and curing agent in the electronic atomization composition, the problems of difficulty in swallowing traditional drugs and easy leakage of solvents are solved, stable packaging and accurate atomization of drugs are achieved, and the safety of drug use is improved and efficiency.
Patent Information
- Application Number
- CN202310600424.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-25
- Publication Date
- 2024-11-26
AI Technical Summary
It is difficult to swallow traditional drugs in children and the elderly, and the drug solvents in traditional electronic atomizers are prone to leak and evaporate, resulting in inaccurate dosage of drugs.
Edible wax is used as an emulsifier and a curing agent to dissolve the drug in the solvent to form a solid electronic atomization composition to avoid leakage and volatility, and to ensure that the drug is uniformly atomized when heated.
It solves the problems of difficulty in swallowing drugs and inaccurate dosage, improves the stability and safety of drugs, and ensures accurate atomization and efficient absorption of drugs.
Smart Images

Figure BDA0004248748080000061 
Figure BDA0004248748080000071
Abstract
Description
Technical Field
[0001] The present application relates to the field of electronic atomization, and specifically to a wax-based electronic atomization composition and a preparation method and application thereof. Background Art
[0002] At present, traditional medicines are generally swallowed. For children and sick elderly people, swallowing medicines is difficult and there is a risk of suffocation. Electronic atomization liquid is an emerging atomization technology that generates aerosols for human inhalation by heating atomization liquid. If traditional medicines are atomized for patients to take, the potential harm that swallowing medicines may cause to children and the elderly will be effectively eliminated. The inventors found that traditional medicines such as azithromycin, ibuprofen, and aspirin are difficult to dissolve in propylene glycol and glycerol systems, and propylene glycol and glycerol systems are the most commonly used atomization solvents for electronic atomization liquids, which greatly affects the application of such drugs for human body delivery through heating and atomization. In addition, traditional atomization liquids are easy-to-flow liquids. During storage, the solvent is very easy to leak and spill. When the solvent leaks and spills, the drug is also lost with the solvent, so that the accurate dosage of the drug cannot be ensured, which in turn hinders the normal use of patients. Summary of the invention
[0003] In order to overcome the problems existing in the above-mentioned prior art, one of the objects of the present invention is to provide a wax-based electronic atomization composition, which uses edible wax as an emulsifier and a curing agent to dissolve the drug in a solvent system to achieve drug encapsulation. The electronic atomization composition solidifies when not in use and does not flow, thereby avoiding leakage, drug suspension or stratification of the electronic atomization composition.
[0004] A second object of the present invention is to provide a method for preparing the wax-based electronic atomization composition.
[0005] The third object of the present invention is to provide application of the above-mentioned wax-based electronic atomization composition in the field of electronic atomization.
[0006] In order to achieve the above object, the technical solution adopted by the present invention is:
[0007] The first aspect of the present invention provides a wax-based electronic atomization composition, comprising the following components by weight: 0.3 to 8 parts of edible wax; 0.01 to 5 parts of medicine; 40 to 165 parts of solvent. The edible waxes in the present invention are all food grade, can be eaten directly, have no side effects on the human body, and are highly safe as components of the electronic atomization composition. On the one hand, the edible wax in the present invention is used as an emulsifier, which can dissolve the medicine that originally has poor solubility in the solvent of the electronic atomization composition in the solvent, enhance the compatibility of the medicine and the solvent, and prevent the medicine from floating out of the solvent system; on the other hand, the edible wax is also used as a curing agent in the present invention. The edible wax encapsulates the solvent and the medicine, so that the liquid electronic atomization composition can be solidified at room temperature, and the solvent will not volatilize or leak. Therefore, the medicine in the electronic atomization composition will not be lost with the volatilization, leakage, etc. of the solvent, ensuring the accuracy of the amount of medicine used during atomization. When atomization is required, the electronic atomization composition in the present invention is dissolved and atomized when heated, and the medicine and edible wax are atomized by the user and atomized by the solvent to achieve atomization. In addition, during storage and transportation, the drugs are encapsulated in a solid wax-based electronic atomization composition, which effectively avoids the occurrence of unstable phenomena such as oxidation, photolysis, and deterioration of the drugs.
[0008] Preferably, the weight proportion of the solvent is 80 to 100 parts; more preferably, the weight proportion of the solvent is 87 to 100 parts.
[0009] Preferably, the weight portion of the edible wax is 0.7 to 8 parts; more preferably, the weight portion of the edible wax is 3 to 8 parts.
[0010] Preferably, the dosage of the drug is 0.03 to 5 parts.
[0011] Preferably, the edible wax is selected from natural waxes, such as at least one of beeswax, palm wax, rice bran wax, candelilla wax, and soybean wax. The edible waxes in the present invention are all food grade, safe and non-toxic, and the preferred edible waxes in the present invention have nutritional value and efficacy. When used as a component in a medical electronic atomization composition, it is beneficial to the user's health and recovery. For example, beeswax has the functions of removing free radicals from the human body, detoxification, and pain relief; rice bran wax is rich in octacosanol, and octacosanol has the functions of improving endurance, energy, and physical strength; improving reaction sensitivity; improving emergency response ability; promoting the action of sex hormones, reducing muscle pain; improving myocardial function; lowering systolic blood pressure; and increasing the body's metabolic rate.
[0012] The drug in the present invention is any drug that can be swallowed or inhaled to treat a disease. Drugs with good solubility and poor solubility are compatible with the solvent in the electronic atomization composition system of the present invention, thereby achieving atomization of the drug. Therefore, the wax-based electronic atomization composition of the present invention has no special requirements for the drug and has a wide range of applications.
[0013] Preferably, the drug is any one of azithromycin, ibuprofen, aspirin, roxithromycin, norfloxacin, metronidazole, rifampicin, acyclovir, ribavirin, artemisinin, meclofenoxate, miconazole and acetaminophen.
[0014] Preferably, the solvent is selected from at least one of propylene glycol, glycerol and ethanol.
[0015] Preferably, the solvent comprises the following components in parts by weight: 40 to 95 parts of propylene glycol; 0 to 50 parts of glycerol; and 0 to 20 parts of ethanol. The solvent of the present invention is used as an atomizing solvent, which can be more compatible with drugs and edible wax.
[0016] Preferably, the wax-based electronic atomization composition further comprises a flavoring agent.
[0017] Preferably, the flavoring agent is used in an amount of 0.01 to 1 part.
[0018] Preferably, the flavoring agent includes at least one of fruity essential oil, cooling agent, and sweetener.
[0019] Preferably, the fruit-flavored essential oils include lemon-flavored essential oils, sweet orange-flavored essential oils, grapefruit-flavored essential oils, tangerine-flavored essential oils, peach-flavored essential oils, and strawberry-flavored essential oils.
[0020] Preferably, the sweetener is selected from at least one of xylitol, maltose, stevioside, rhamnose, trehalose, erythritol, lactose and galactose.
[0021] Preferably, the cooling agent is selected from at least one of menthol, menthone, isomenthone and menthyl lactate.
[0022] The second aspect of the present invention is to provide a method for preparing the wax-based electronic atomization composition provided in the first aspect of the present invention, comprising the following steps: mixing a solvent, edible wax and a drug under heating, and then cooling to obtain the wax-based electronic atomization composition.
[0023] Preferably, the heating temperature is 60-100°C.
[0024] Preferably, the cooling temperature is 10-35°C; more preferably, the cooling temperature is 20-30°C.
[0025] Preferably, the step of mixing the solvent, edible wax and the drug under heating is: mixing the solvent, edible wax and the drug in sequence at 60-100°C.
[0026] Preferably, the preparation method of the wax-based electronic atomization composition is specifically as follows:
[0027] S1 weighs the solvent according to the formula amount, and heats and mixes it in a closed environment;
[0028] S2 adds edible wax to the liquid in S1, and heats and mixes until completely dissolved;
[0029] S3: adding the drug to the solution in step S2, heating and mixing until completely dissolved;
[0030] S4: Cooling the liquid in step S3 at 20-30° C. to obtain the wax-based electronic atomization composition.
[0031] Preferably, the heating temperature in step S1, step S2 or step S3 is 60-100°C.
[0032] The third aspect of the present invention is to provide the application of the wax-based electronic atomization composition provided in the first aspect of the present invention in the field of electronic atomization.
[0033] The beneficial effects of the present invention are: for the first time, edible wax is used as an emulsifier and a curing agent to disperse the drug in a solvent, and a solid electronic atomization composition of commonly used drugs is prepared. Heating and atomizing the composition for inhalation can effectively solve the problems of children's difficulty in swallowing drugs and possible suffocation. In addition, compared with conventional atomization liquids, the wax-based electronic atomization composition of the present invention solves the problems of oil leakage, splattering, drug suspension and stratification in the atomization composition, and the dosage of the drug is more accurate when atomizing the drug, and the use safety is higher, which provides a reference idea for the atomization of traditional drugs.
[0034] In addition, the preparation method of the wax-based electronic atomization composition of the present invention does not require complicated production equipment and operation steps, and can be prepared at a temperature of 60 to 100° C. The preparation conditions are mild and meet the requirements of mass production. DETAILED DESCRIPTION
[0035] The specific implementation of the present invention is further described in detail below in conjunction with examples, but the implementation and protection of the present invention are not limited thereto. It should be noted that if there are processes that are not particularly described in detail below, they can be implemented or understood by those skilled in the art with reference to the prior art. If the manufacturer of the reagents or instruments used is not indicated, they are deemed to be conventional products that can be purchased commercially.
[0036] Example 1
[0037] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0038] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0039] (1) Weigh 6 g of propylene glycol, 1.969 g of glycerol, and 2 g of ethanol, heat at 60° C. in a closed environment and stir until the mixture is uniform;
[0040] (2) adding 0.03 g of beeswax to the liquid of step (1), and continuing to heat at 60° C. and stirring until completely dissolved;
[0041] (3) Add 0.001 g of azithromycin to the solution of step (2), and heat with stirring at 60° C. until it is completely dissolved.
[0042] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0043] Example 2
[0044] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0045] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0046] (1) Weigh 4 g of propylene glycol, 5 g of glycerol, and 0.958 g of ethanol, heat at 70°C in a closed environment and stir until the mixture is uniform;
[0047] (2) adding 0.04 g of palm wax to the liquid of step (1) and continuing to heat at 70° C. and stirring until completely dissolved;
[0048] (3) Add 0.002 g of ibuprofen to the solution of step (2), and heat with stirring at 70° C. until it is completely dissolved.
[0049] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0050] Example 3
[0051] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0052] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0053] (1) Weigh 9.5 g of propylene glycol and 0.427 g of ethanol, heat at 80° C. in a closed environment and stir until the mixture is uniform;
[0054] (2) adding 0.07 g of rice bran wax to the liquid of step (1) and continuing to heat and stir at 80° C. until it is completely dissolved;
[0055] (3) Add 0.003 g of aspirin to the solution of step (2), and heat at 80° C. with stirring until it is completely dissolved.
[0056] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0057] Example 4
[0058] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0059] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0060] (1) Weigh 8 g of propylene glycol, 0.5 g of glycerol, and 1 g of ethanol, heat at 90° C. in a closed environment and stir until the mixture is uniform;
[0061] (2) adding 0.3 g of candelilla wax to the liquid of step (1) and heating at 90° C. with stirring until completely dissolved;
[0062] (3) Add 0.02 g of metronidazole to the solution of step (2), and heat with stirring at 90° C. until it is completely dissolved.
[0063] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0064] Example 5
[0065] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0066] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0067] (1) Weigh 7 g of propylene glycol and 1.7 g of ethanol, heat at 100° C. in a closed environment and stir until the mixture is uniformly mixed;
[0068] (2) adding 0.8 g of palm wax to the liquid of step (1) and continuing to heat at 100° C. and stirring until completely dissolved;
[0069] (3) Add 0.5 g of roxithromycin to the solution of step (2), and heat and stir at 100° C. until it is completely dissolved.
[0070] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0071] Example 6
[0072] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0073] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0074] (1) Weigh 7 g of propylene glycol, 2 g of propylene glycol, and 1 g of ethanol, heat at 100° C. in a closed environment and stir until the mixture is uniformly mixed;
[0075] (2) adding 0.2 g of beeswax and 0.2 g of palm wax to the liquid of step (1), and continuing to heat at 100° C. and stirring until completely dissolved;
[0076] (3) Add 0.05 g of norfloxacin to the solution of step (2), and heat and stir at 100° C. until the solution is completely dissolved.
[0077] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0078] Example 7
[0079] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0080] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0081] (1) Weigh 8 g of propylene glycol, 1 g of glycerol, and 1 g of ethanol, heat at 85° C. in a closed environment and stir until the mixture is uniform;
[0082] (2) adding 0.1 g of soybean wax, 0.1 g of rice bran wax, and 0.1 g of candelilla wax to the liquid of step (1) and continuing to heat at 85° C. and stirring until completely dissolved;
[0083] (3) Add 0.03 g of rifampicin to the solution of step (2), and heat with stirring at 60° C. until it is completely dissolved.
[0084] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0085] Example 8
[0086] The wax-based electronic atomization composition in this example is prepared using the corresponding raw material ratios in Table 1.
[0087] The preparation method of the wax-based electronic atomization composition in this example comprises the following steps:
[0088] (1) Weigh 8 g of propylene glycol and 2 g of ethanol, heat at 80° C. in a closed environment and stir until the mixture is uniform;
[0089] (2) adding 0.1 g beeswax, 0.2 g palm wax and 0.1 g rice bran wax to the liquid of step (1) and continuing to heat at 80° C. and stirring until completely dissolved;
[0090] (3) Add 0.1 g of acetaminophen to the solution of step (2), and heat at 60° C. with stirring until it is completely dissolved.
[0091] (4) Cooling the liquid in step (3) at room temperature to obtain the wax-based electronic atomization composition in this example.
[0092] Table 1 Raw material ratios of the wax-based electronic atomization compositions in Examples 1 to 8
[0093]
[0094]
[0095] Comparative Examples 1 to 8
[0096] The wax-based electronic atomization compositions in Comparative Examples 1 to 8 were prepared using the corresponding raw material ratios in Table 2.
[0097] The preparation methods of the wax-based electronic atomization compositions in Comparative Examples 1 to 8 are prepared by referring to the preparation methods in Examples 1 to 8, respectively; the preparation methods of the wax-based electronic atomization compositions in Comparative Examples 1 to 8 do not include step (2), that is, the preparation methods of the wax-based electronic atomization compositions in Comparative Examples 1 to 8 do not require the addition of edible wax for mixing.
[0098] Table 2 Raw material ratios of the wax-based electronic atomization compositions in Comparative Examples 1 to 8
[0099] Comparative Example Propylene glycol (g) Glycerol(g) Ethanol(g) Drug(g) 1 6 1.969 2 0.001 g azithromycin 2 4 5 0.958 0.002g ibuprofen 3 9.5 0.427 0.003 g aspirin 4 8 0.5 1 0.02 g metronidazole 5 7 1.7 0.5g roxithromycin 6 7 2 1 0.05g norfloxacin 7 8 1 1 0.03 g rifampicin 8 8 2 0.1 g acetaminophen
[0100] Performance Testing
[0101] The wax-based electronic atomization compositions prepared in Examples 1 to 8 and Comparative Examples 1 to 8 were respectively tested as follows:
[0102] (1) Oil leakage test: 100 electronic atomization devices were stored in an environment with a temperature of 45°C and an air humidity of 80% for 7 days. After 7 days, the number of electronic atomization devices leaking oil was observed.
[0103] (2) Dissolution test: observe whether the aerosol composition shows drug suspension and stratification.
[0104] The specific test results are recorded in Table 3 below.
[0105] Table 3 Test results of wax-based electronic atomization compositions in Examples 1 to 8 and Comparative Examples 1 to 8
[0106] Atomization composition Oil leakage test (number of oil leaks) Dissolution test Example 1 2 No precipitation Example 2 1 No precipitation Example 3 0 No precipitation Example 4 0 No precipitation Example 5 0 No precipitation Example 6 0 No precipitation Example 7 0 No precipitation Example 8 0 No precipitation Comparative Example 1 27 Drug suspension Comparative Example 2 26 Drug suspension Comparative Example 3 24 Drug suspension Comparative Example 4 19 Drug suspension Comparative Example 5 24 Drug suspension Comparative Example 6 18 Drug suspension Comparative Example 7 29 Drug suspension
[0107] It can be seen from Table 3 above that, compared with Comparative Examples 1 to 8, Examples 1 to 8 of the present invention introduce edible wax into the electronic atomization composition system, and use edible wax as an emulsifier and a curing agent to evenly disperse the drug in the solvent (a solvent system formed by propylene glycol, glycerol or ethanol), thereby achieving drug encapsulation. The prepared electronic atomization composition hardly leaks during storage, and the solubility of the drug is also greatly improved. No drug stratification or suspension phenomenon is found during use, which solves the problem that the existing electronic atomization liquid containing drugs is all liquid, and there is leakage, drug stratification or suspension during use.
[0108] The embodiments of the present invention may also add more or less solvent, such as 40-160 parts, to achieve the purpose of the present invention.
[0109] The above is a detailed description of the embodiments of the present invention, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.
Claims
1. A wax-based electronic atomization composition, Features: The invention comprises the following components in parts by weight: 0.3 to 8 parts of edible wax; 0.01 to 5 parts of medicine; and 40 to 165 parts of solvent.
2. The wax-based electronic atomization composition according to claim 1, Features: The edible wax is selected from at least one of beeswax, palm wax, rice bran wax, candelilla wax and soybean wax.
3. The wax-based electronic atomization composition according to claim 1, Features: The drug is any one of azithromycin, ibuprofen, aspirin, roxithromycin, norfloxacin, metronidazole, rifampicin, acyclovir, ribavirin, artemisinin, meclofenoxate, miconazole and acetaminophen.
4. The wax-based electronic atomization composition according to claim 1, Features: The solvent is selected from at least one of propylene glycol, glycerol and ethanol.
5. The wax-based electronic atomization composition according to claim 1 or 4, Features: The solvent comprises the following components in parts by weight: 40 to 95 parts of propylene glycol; 0 to 50 parts of glycerol; and 0 to 20 parts of ethanol.
6. A method for preparing the wax-based electronic atomization composition according to any one of claims 1 to 5, Features: The following steps are involved: The solvent, edible wax and medicine are mixed under heating and then cooled to prepare the wax-based electronic atomization composition.
7. The method for preparing the wax-based electronic atomization composition according to claim 6, Features: The heating temperature is 60-100°C.
8. The method for preparing the wax-based electronic atomization composition according to claim 6, Features: The cooling temperature is 10-35°C.
9. The method for preparing the wax-based electronic atomization composition according to claim 6, Features: The step of mixing the solvent, edible wax and medicine under heating is specifically: mixing the solvent, edible wax and medicine in sequence at 60-100°C.
10. Use of the wax-based electronic atomization composition according to any one of claims 1 to 5 in the field of electronic atomization.
